drugset / Trial / NCT00144248

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

NCT00144248

Phase 4 Completed 51 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study was to evaluate the steady-state clearance of nevirapine among HIV-1 positive patients with hepatic fibrosis, and to examine whether the degree of hepatic impairment influences clearance.

Timeline

Start
2004-06-25
Primary completion
2006-06-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nevirapine Small molecule